Market leader in peptide API manufacturing and services
PolyPeptide is a Contract Development & Manufacturing Organization (CDMO) supporting pharmaceutical and biotech companies in the development and manufacturing of proprietary and generic active pharmaceutical ingredients (API).
PolyPeptide with record revenue growth of 43% in H2 2023 versus H1 2023; operational improvements yielding increased profitability and cash flow
12 Mar 2024 - Baar, 12 March 2024 – PolyPeptide Group AG (SIX: PPGN), a focused global CDMO for peptide- and oligonucleotide-based active pharmaceutical ingredients, today announced its results for […]
Read morePolyPeptide signs scientific collaboration agreement
31 Oct 2023 - Strasbourg, 31 October 2023 – PolyPeptide today announced the signing of a collaboration agreement with the Peptide Sciences Laboratory of the University of KwaZulu-Natal (UKZN) in […]
Read more